Search results
ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry.
Healthcare Intelligence. Clinical Research. Evolved. Play. Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life.
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotech
ICON plc is a global leader in clinical research and healthcare innovation. Our presence in India is marked by a fusion of international expertise and local talent, creating a dynamic environment where ambitious professionals thrive.
Dublin, Ireland, February 22, 2022 – ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today reported its financial results for the fourth quarter and full year ended December 31, 2021.
Jun 4, 2024 · Investor Information. ICON is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations.
5 days ago · Navigating oncology development decisions for long-term success. Oncology clinical development is often at the leading edge of innovative approaches to study designs through the use of novel approaches to enhanced patient care and clinically relevant endpoints. 1,2 Oncology has made substantial progress in the last 10 years.
Feb 22, 2022 · ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations.
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance. 20 May, 2024. ICON plc to hold Investor Day Meeting on May 30, 2024. 09 May, 2024. ICON releases its ICON Cares 2023 Report. 30 April, 2024. ICON Announces Pricing of USD 2 Billion Notes. 24 April, 2024. ICON Reports First Quarter 2024 Results.
